Reach Us +1-504-608-2390
Perioperative Intravenous Corticosteroids Reduce Incidence Of Atrial Fibrillation Following Cardiac Surgery - A Randomized, Double Blinded Placebocontrolled Study | 7870
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Perioperative Intravenous Corticosteroids Reduce incidence of Atrial Fibrillation Following Cardiac Surgery - A randomized, double blinded placebocontrolled study

2nd International Conference on Clinical Research Cardiology, Ophthalmology & Dermatology

Abbaszadeh M, Mehrani F, Hussain khan Z

Posters: J Clinic Experiment Cardiol

DOI: 10.4172/2155-9880.S1.06

Objective: Corticosteroids decrease side effects after noncardiac elective surgery. We designed this randomized, double blinded, placebo- controlled study to test the hypothesis that standard doses of dexamethasone (6?2) would decrease the incidence of atrial fibrillation (AF)following cardiac surgery. Methods: A total of 185 patients undergoing coronary revascularization surgery were enrolled in thisclinical study. The anesthetic management was standardized in all patients. Dexamethasone (6mg/mL) or saline (1mL) was administered after the induction of anesthesia and a second dose of the same study drug was given on the morning after surgery. The incidence of (AF) was determined by analyzing the first 72 h of continuously recorded electrocardiogram records after cardiac surgery, to determine the incidence and severity of postoperative side effects. Results: The incidence of 48 h postoperative AF was significantly lower in the Dexamethasone group (21/92[37.5%]) than in the placebo group (35/92 [62.5%], adjusted hazard ratio, 2.07; 95% confidence interval, 1.09-3.95; p= (P<0.05). Compared with placebo, patients receiving hydrocortisone did not have higher rates of superficial or deep wound infections, or other major complications. Conclusions: prophylactic short- term dexamethasone administration in patients undergoing coronary artery bypasses grafting significantly reduced postoperative atrial fibrillation
Relevant Topics